The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Previous Angina Alters In-Hospital Outcome in TIMI 4: A Clinical Correlate to Preconditioning?
Abstract
Background Ischemic preconditioning has been shown to reduce myocardial infarct size in experimental models, but its role in patients remains unclear. Angina before myocardial infarction reflects brief episodes of ischemia and may be a marker of preconditioning. As part of the Thrombolysis in Myocardial Infarction (TIMI) 4 study, we performed an analysis on the effect of a history of previous angina on in-hospital outcomes for patients with acute myocardial infarction. Methods and Results Patients eligible for thrombolytic therapy were enrolled into the study. Data were collected from case report forms regarding previous history of angina, in-hospital outcome and 6-week follow-up. Two hundred eighteen patients had a history of previous angina at any time before acute myocardial infarction, and 198 patients did not have previous angina. Patients with any previous history of angina were less likely than with those without angina to experience in-hospital death (3% versus 8%) ( P =.03), severe congestive heart failure (CHF) or shock (1% versus 7%, P =.006), or the combined end point of in-hospital death, severe CHF, or shock (4% versus 12%, P =.004). Moreover, patients with any history of angina were more likely to have a smaller creatine kinase (CK)-determined infarct size (119 versus 154 CK integrated units; P =.01) and were less likely to have Q waves on their ECG (57% versus 69%; P =.01). In the subset of patients who experienced angina within the 48 hours before infarction (compared with those who did not), there was a trend toward less likely in-hospital death (3% versus 6%; P =.09), a lower incidence of severe CHF or shock (1% versus 6% P =.008), a lower combined end point of death, CHF, or shock (3% versus 10%; P =.006), smaller infarct size assessed by CK (115 versus 151 CK units; P =.03), and a trend toward fewer Q-wave infarcts. However, patients with a history of previous angina did have a trend toward more recurrent ischemic pain. Of importance is that the beneficial in-hospital effects of previous angina were not dependent on angiographically visible coronary collaterals. Conclusions Previous angina confers a beneficial effect on in-hospital outcome after acute myocardial infarction. The reasons for this benefit are uncertain, but one potential mechanism for this observation may be ischemic preconditioning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,812
Liu, G. S., Thornton, J., Van Winkle, D. M., Stanley, A. W., Olsson, R. A., & Downey, J. M. (1991) · Circulation · doi:10.1161/01.cir.84.1.350 · Cited by 1,351
Marber, M. S., Latchman, D. S., Walker, J. M., & Yellon, D. M. (1993) · Circulation · doi:10.1161/01.cir.88.3.1264 · Cited by 1,001
Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.
Gross, G. J., & Auchampach, J. A. (1992) · Circulation Research · doi:10.1161/01.res.70.2.223 · Cited by 949
Deanfield, J. E., Selwyn, A. P., Chierchia, S., Maseri, A., Ribeiro, P., Krikler, S., & Morgan, M. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92295-x · Cited by 719
Preconditioning the human myocardium
Yellon, D. M., Alkhulaifi, A. M., & Pugsley, W. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)91819-8 · Cited by 712
Deutsch, E., Berger, M., Kussmaul, W. G., Hirshfeld, J. W., Herrmann, H. C., & Laskey, W. K. (1990) · Circulation · doi:10.1161/01.cir.82.6.2044 · Cited by 594
Ischemic preconditioning reduces infarct size in swine myocardium.
Schott, R. J., Rohmann, S., Braun, E. R., & Schaper, W. (1990) · Circulation Research · doi:10.1161/01.res.66.4.1133 · Cited by 559
Thornton, J. D., Liu, G. S., Olsson, R. A., & Downey, J. M. (1992) · Circulation · doi:10.1161/01.cir.85.2.659 · Cited by 451
Cribier, A., Korsatz, L., Koning, R., Rath, P., Gamra, H., Stix, G., Merchant, S., Chan, C., & Letac, B. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90011-b · Cited by 244
Cited by
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062
Postconditioning the Human Heart
Staat, P., Rioufol, G., Piot, C., Cottin, Y., Cung, T. T., L’Huillier, I., Aupetit, J.-F., Bonnefoy, E., Finet, G., André-Fouët, X., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.558122 · Cited by 999
Tumor necrosis factor in the heart
Meldrum, D. R. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r577 · Cited by 746
Ferdinandy, P., Schulz, R., & Baxter, G. F. (2007) · Pharmacological Reviews · doi:10.1124/pr.107.06002 · Cited by 744
Heusch, G., & Gersh, B. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw224 · Cited by 676
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Kloner, R. A., & Jennings, R. B. (2001) · Circulation · doi:10.1161/hc4801.100038 · Cited by 634
Self-citationRezkalla, S. H., & Kloner, R. A. (2002) · Circulation · doi:10.1161/hc0502.102867 · Cited by 621
Self-citationHeart Failure After Myocardial Infarction: Incidence and Predictors
Jenča, D., Melenovský, V., Stehlik, J., Staněk, V., Kettner, J., Kautzner, J., Adámková, V., & Wohlfahrt, P. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13144 · Cited by 605
Rapola, J. M., Virtamo, J., Ripatti, S., Huttunen, J. K., Albanes, D., Taylor, P. R., & Heinonen, O. P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01234-8 · Cited by 569
Nuclear factor kappa-B and the heart
Valen, G., Yan, Z.-Q., & Hansson, G. K. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01377-8 · Cited by 447
Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning: An NHLBI Workshop
Kloner, R. A., Bolli, R., Marban, E., Reinlib, L., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.97.18.1848 · Cited by 440
Self-citationRaedschelders, K., Ansley, D. M., & Chen, D. D. Y. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.11.004 · Cited by 388
ATP-sensitive K+channels in pancreatic, cardiac, and vascular smooth muscle cells
Yokoshiki, H., Sunagawa, M., Seki, T., & Sperelakis, N. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c25 · Cited by 350
Loss of cardioprotection with ageing
Boengler, K., Schulz, R., & Heusch, G. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp033 · Cited by 328
Cleveland, J. C., Meldrum, D. R., Cain, B. S., Banerjee, A., & Harken, A. H. (1997) · Circulation · doi:10.1161/01.cir.96.1.29 · Cited by 294
Speechly-Dick, M. E., Grover, G. J., & Yellon, D. M. (1995) · Circulation Research · doi:10.1161/01.res.77.5.1030 · Cited by 289
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 2
Kloner, R. A., & Jennings, R. B. (2001) · Circulation · doi:10.1161/hc5001.100039 · Cited by 286
Self-citationIschemic Preconditioning in Humans: Models, Mediators, and Clinical Relevance
Tomai, F., Crea, F., Chiariello, L., & Gioffrè, P. A. (1999) · Circulation · doi:10.1161/01.cir.100.5.559 · Cited by 274
Ischaemic preconditioning: present position and future directions
Yellon, D. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00214-9 · Cited by 257
Nitrite as a mediator of ischemic preconditioning and cytoprotection
Murillo, D., Kamga, C., Mo, L., & Shiva, S. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.01.003 · Cited by 57
Metadata
- Authors
- Kloner, R. A., Shook, T., Przyklenk, K., Davis, V. G., Junio, L., Matthews, R. V., Burstein, S., Gibson, C. M., Poole, W. K., Cannon, C. P., McCabe, C. H., & Braunwald, E.
- Venue
- Circulation
- Published
- 1995-01
- Volume
- 91
- Issue
- 1
- Pages
- 37-45
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2088043482
- Cited by
- 528
- References
- 17
- FWCI
- 38.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.